CG-5-treated mice exhibited decreased number of total spleen cells as well as CD4+ T cells (not shown), indicating that CG-5 inhibits CD4+ T cell expansion in GVHD responses, in agreement with the previous alloreactivity experiment (Figure 4). Here, CD4 is linked to graft versus host disease.